Clinical trials
Full profile accessFollow clinical development from study design and recruitment through results.
- Trial phase
- Status
- Readouts
Drug intelligence / Profile preview
Fermented rice bran is a **microbially processed rice bran nutraceutical/dietary supplement** rather than a single defined pharmaceutical active ingredient. Across the cited literature, it is produced by fermenting rice bran with varying microbial consortia such as *Bacillus*, *Lactobacillus*, *Bifidobacterium*, *Aspergillus*, or yeast, which can increase bioavailable amino acids, gamma-aminobutyric acid, antioxidant metabolites, and vitamin B12 forms while reducing antinutritional factors and rancidity. Its reported biological effects are pleiotropic and formulation-dependent, with preclinical evidence for immunomodulatory, metabolic, gut-barrier, antioxidant, and antiviral benefits; however, there is no single validated molecular target or standardized drug product that applies across all fermented rice bran preparations. In the provided human trial context, fermented rice bran appears as a **component** of the hangover supplement Myrkl's AB001 formulation rather than as the sole branded product itself.
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Follow clinical development from study design and recruitment through results.
Explore development by indication, patient population, and geography.
Trace asset ownership, licensing agreements, and commercial partnerships.
Explore the patent landscape and regulatory exclusivity around an asset.
Compare development programs by target, modality, and indication.
Connect source evidence and development news to your research questions.
See how Gosset can support your research on fermented rice bran.